Literature DB >> 12423110

Protein-cleaving catalyst selective for protein substrate.

Joong Won Jeon1, Sang Jun Son, Chang Eun Yoo, In Seok Hong, Jung Bae Song, Junghun Suh.   

Abstract

A protein-cleaving catalyst specific for a disease-related protein can be used as a catalytic drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin was designed by attaching Cu(II) or Co(III) complex of cyclen to a binding site searched by a combinatorial method using peptide nucleic acid monomers as building units. [reaction: see text]

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423110     DOI: 10.1021/ol0269300

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  11 in total

1.  Cleavage agents for soluble oligomers of human islet amyloid polypeptide.

Authors:  Junghun Suh; Woo Suk Chei; Tae Yeon Lee; Min Gyum Kim; Sang Ho Yoo; Keunhong Jeong; Jae Young Ahn
Journal:  J Biol Inorg Chem       Date:  2008-03-05       Impact factor: 3.358

2.  Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: Toward dual-action therapeutics.

Authors:  Nikhil H Gokhale; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2006-07-28       Impact factor: 3.358

3.  Peptide-cleaving catalyst selective for melanin-concentrating hormone: Oxidative decarboxylation of N-terminal aspartate catalyzed by Co(III)cyclen.

Authors:  Min Gyum Kim; Myoung-soon Kim; Seong Du Lee; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2006-07-13       Impact factor: 3.358

4.  Soluble artificial metalloproteases with broad substrate selectivity, high reactivity, and high thermal and chemical stabilities.

Authors:  Min Gyum Kim; Sang Ho Yoo; Woo Suk Chei; Tae Yeon Lee; Hye Mi Kim; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2010-04-28       Impact factor: 3.358

5.  Angiotensin-cleaving catalysts: conversion of N-terminal aspartate to pyruvate through oxidative decarboxylation catalyzed by Co(III)cyclen.

Authors:  Myoung-Soon Kim; Joong Won Jeon; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2005-05-11       Impact factor: 3.358

6.  New chelating ligands for Co(III)-based peptide-cleaving catalysts selective for pathogenic proteins of amyloidoses.

Authors:  Woo Suk Chei; Heeyeon Ju; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2010-12-18       Impact factor: 3.358

7.  Proteolytic activity of Co(III) complex of 1-oxa-4,7,10-triazacyclododecane: a new catalytic center for peptide-cleavage agents.

Authors:  Hye Mi Kim; Boonjae Jang; Young Eun Cheon; Myunghyun Paik Suh; Junghun Suh
Journal:  J Biol Inorg Chem       Date:  2008-10-05       Impact factor: 3.358

8.  Binding of HIV-1 TAR mRNA to a peptide nucleic acid oligomer and its conjugates with metal-ion-binding multidentate ligands.

Authors:  Matthew J Belousoff; Gilles Gasser; Bim Graham; Yitzhak Tor; Leone Spiccia
Journal:  J Biol Inorg Chem       Date:  2008-11-18       Impact factor: 3.358

9.  Metallotherapeutics: novel strategies in drug design.

Authors:  Lalintip Hocharoen; James A Cowan
Journal:  Chemistry       Date:  2009-09-07       Impact factor: 5.236

10.  Polyurethane with tethered copper(II)-cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols.

Authors:  Sangyeul Hwang; Mark E Meyerhoff
Journal:  Biomaterials       Date:  2008-03-07       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.